Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations’) read with Schedule III of Listing Regulations, Wockhardt has informed the Exchanges that the Credit Facilities Committee of the Board of Directors of the Company, at its meeting held on 28th May, 2021, allotted 5,000 Nos. of Rated, Unlisted, Secured Non-Convertible Debentures (‘NCDs’) of face value of Rs. 1,00,000 each for an aggregate value of Rs 50 crore (Series B Tranche I) to Centrum Credit Opportunities Trust on private placement basis on the terms and conditions as stipulated in the debenture trust deed dated 27th April 2021, as amended from time to time and other transaction documents, as amended from time to time.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: